US3993754A
(en)
|
1974-10-09 |
1976-11-23 |
The United States Of America As Represented By The United States Energy Research And Development Administration |
Liposome-encapsulated actinomycin for cancer chemotherapy
|
US4086257A
(en)
|
1976-10-12 |
1978-04-25 |
Sears Barry D |
Phosphatidyl quaternary ammonium compounds
|
CH624011A5
(zh)
|
1977-08-05 |
1981-07-15 |
Battelle Memorial Institute |
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4522803A
(en)
|
1983-02-04 |
1985-06-11 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles, their preparation and use
|
US4588578A
(en)
|
1983-08-08 |
1986-05-13 |
The Liposome Company, Inc. |
Lipid vesicles prepared in a monophase
|
US5208036A
(en)
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
US5286634A
(en)
|
1989-09-28 |
1994-02-15 |
Stadler Joan K |
Synergistic method for host cell transformation
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
US5756353A
(en)
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
WO1993023011A1
(en)
|
1992-05-18 |
1993-11-25 |
Minnesota Mining And Manufacturing Company |
Transmucosal drug delivery device
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5426039A
(en)
|
1993-09-08 |
1995-06-20 |
Bio-Rad Laboratories, Inc. |
Direct molecular cloning of primer extended DNA containing an alkane diol
|
FR2715847B1
(fr)
|
1994-02-08 |
1996-04-12 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
FR2722506B1
(fr)
|
1994-07-13 |
1996-08-14 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucleiques, preparation et utilisations
|
US5908635A
(en)
|
1994-08-05 |
1999-06-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for the liposomal delivery of nucleic acids
|
CA2200952C
(en)
|
1994-09-30 |
2006-04-11 |
Inex Pharmaceuticals Corp. |
Novel compositions comprising quaternary ammonium compounds and neutral lipids for the introduction of polyanionic materials into cells
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
US5753613A
(en)
|
1994-09-30 |
1998-05-19 |
Inex Pharmaceuticals Corporation |
Compositions for the introduction of polyanionic materials into cells
|
US5580579A
(en)
|
1995-02-15 |
1996-12-03 |
Nano Systems L.L.C. |
Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
US5705385A
(en)
|
1995-06-07 |
1998-01-06 |
Inex Pharmaceuticals Corporation |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
IL122290A0
(en)
|
1995-06-07 |
1998-04-05 |
Inex Pharmaceuticals Corp |
Lipid-nucleic acid complex its preparation and use
|
US5756122A
(en)
|
1995-06-07 |
1998-05-26 |
Georgetown University |
Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells
|
US5981501A
(en)
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
IL115199A
(en)
|
1995-09-07 |
2005-05-17 |
Opperbas Holding Bv |
Composition comprising a polynucleic acid molecule in a liposome and method using said composition
|
US6620805B1
(en)
|
1996-03-14 |
2003-09-16 |
Yale University |
Delivery of nucleic acids by porphyrins
|
EP0918790B1
(en)
|
1996-05-24 |
2004-01-28 |
Ic-Vec Limited |
Polycationic sterol derivatives as transfection agents
|
WO1998006437A2
(en)
|
1996-08-13 |
1998-02-19 |
Chiron Corporation |
Compositions and methods for polynucleotide delivery
|
US6126965A
(en)
|
1997-03-21 |
2000-10-03 |
Georgetown University School Of Medicine |
Liposomes containing oligonucleotides
|
US20030229040A1
(en)
|
1997-03-21 |
2003-12-11 |
Georgetown University |
Cationic liposomal delivery system and therapeutic use thereof
|
DE69841002D1
(de)
|
1997-05-14 |
2009-09-03 |
Univ British Columbia |
Hochwirksame verkapselung von nukleinsäuren in lipidvesikeln
|
US6887906B1
(en)
|
1997-07-01 |
2005-05-03 |
Isispharmaceuticals, Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
US20030073640A1
(en)
|
1997-07-23 |
2003-04-17 |
Ribozyme Pharmaceuticals, Inc. |
Novel compositions for the delivery of negatively charged molecules
|
AU8428998A
(en)
|
1997-07-24 |
1999-02-16 |
Inex Pharmaceuticals Corporation |
Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method
|
JP2001510808A
(ja)
|
1997-07-24 |
2001-08-07 |
イネックス ファーマシューティカルズ コーポレイション |
核酸触媒の供給のためのリポソーム組成物
|
US6320017B1
(en)
|
1997-12-23 |
2001-11-20 |
Inex Pharmaceuticals Corp. |
Polyamide oligomers
|
US6509323B1
(en)
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
US7091192B1
(en)
|
1998-07-01 |
2006-08-15 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
CA2335393C
(en)
|
1998-07-20 |
2008-09-23 |
Inex Pharmaceuticals Corporation |
Liposomal encapsulated nucleic acid-complexes
|
ATE511543T1
(de)
|
1999-02-22 |
2011-06-15 |
Univ Georgetown |
Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung
|
US6852334B1
(en)
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
WO2000062813A2
(en)
|
1999-04-20 |
2000-10-26 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
US7112337B2
(en)
|
1999-04-23 |
2006-09-26 |
Alza Corporation |
Liposome composition for delivery of nucleic acid
|
US7098032B2
(en)
|
2001-01-02 |
2006-08-29 |
Mirus Bio Corporation |
Compositions and methods for drug delivery using pH sensitive molecules
|
US6200599B1
(en)
|
1999-10-07 |
2001-03-13 |
The Regents Of The University Of California |
Ortho ester lipids
|
US20050037086A1
(en)
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
AU2001247924A1
(en)
|
2000-03-29 |
2001-10-08 |
Aradigm Corporation |
Cationic liposomes
|
US7189705B2
(en)
|
2000-04-20 |
2007-03-13 |
The University Of British Columbia |
Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
|
AU2001268159B2
(en)
|
2000-06-02 |
2005-09-15 |
Eisai Inc. |
Delivery systems for bioactive agents
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
US7427394B2
(en)
|
2000-10-10 |
2008-09-23 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
US7053150B2
(en)
|
2000-12-18 |
2006-05-30 |
Nektar Therapeutics Al, Corporation |
Segmented polymers and their conjugates
|
TW593427B
(en)
|
2000-12-18 |
2004-06-21 |
Nektar Therapeutics Al Corp |
Synthesis of high molecular weight non-peptidic polymer derivatives
|
TWI321054B
(en)
|
2000-12-19 |
2010-03-01 |
California Inst Of Techn |
Compositions containing inclusion complexes
|
HUP0303616A3
(en)
|
2001-03-26 |
2006-07-28 |
Alza Corp Mountain View |
Liposome composition for improved intracellular delivery of a therapeutic agent
|
WO2002076427A2
(en)
|
2001-03-26 |
2002-10-03 |
Thomas Jefferson University |
Ph sensitive liposomal drug delivery
|
US20030026831A1
(en)
|
2001-04-20 |
2003-02-06 |
Aparna Lakkaraju |
Anionic liposomes for delivery of bioactive agents
|
WO2002087541A1
(en)
|
2001-04-30 |
2002-11-07 |
Protiva Biotherapeutics Inc. |
Lipid-based formulations for gene transfer
|
JP2004535388A
(ja)
|
2001-04-30 |
2004-11-25 |
ターゲティッド ジェネティクス コーポレイション |
脂質含有薬物送達複合体およびそれらの生成方法
|
DE10127526A1
(de)
|
2001-05-31 |
2002-12-12 |
Novosom Ag |
Verfahren zur Herstellung und Auflösung von Nano- und Mikrokapseln
|
US7063860B2
(en)
|
2001-08-13 |
2006-06-20 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
US7101995B2
(en)
|
2001-08-27 |
2006-09-05 |
Mirus Bio Corporation |
Compositions and processes using siRNA, amphipathic compounds and polycations
|
DE10152145A1
(de)
|
2001-10-19 |
2003-05-22 |
Novosom Ag |
Stabilisierung von Liposomen und Emulsionen
|
EP1575976A4
(en)
|
2001-11-02 |
2006-08-23 |
Insert Therapeutics Inc |
METHODS AND COMPOSITIONS FOR THE THERAPEUTIC USE OF RNA INTERFERENCE
|
DE10157046A1
(de)
|
2001-11-18 |
2003-06-12 |
Novosom Ag |
Nano- und Mikrokapseln umfassend Reaktivpolymere
|
WO2003057190A1
(en)
|
2001-12-31 |
2003-07-17 |
Elan Pharmaceuticals, Inc. |
Efficient nucleic acid encapsulation into medium sized liposomes
|
CA2472462A1
(en)
|
2002-01-09 |
2003-07-24 |
Elan Pharmaceuticals, Inc. |
Efficient nucleic acid encapsulation into medium sized liposomes
|
EP1480657A4
(en)
|
2002-02-01 |
2006-07-05 |
Intradigm Corp |
POLYMERS FOR ADMINISTERING PEPTIDES AND SMALL MOLECULES IN VIVO / I
|
DE10207177A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Fakultativ kationische Lipide
|
US20050222064A1
(en)
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
EP1476492A1
(en)
|
2002-02-22 |
2004-11-17 |
Insert Therapeutics Inc. |
Carbohydrate-modified polymers, compositions and uses related thereto
|
US7037520B2
(en)
|
2002-03-22 |
2006-05-02 |
Baylor College Of Medicine |
Reversible masking of liposomal complexes for targeted delivery
|
WO2003083443A2
(en)
|
2002-03-29 |
2003-10-09 |
University Of Florida |
Lipid mediated screening of drug candidates for identification of active compounds
|
WO2003099225A2
(en)
|
2002-05-24 |
2003-12-04 |
Mirus Corporation |
Compositions for delivering nucleic acids to cells
|
ATE485031T1
(de)
|
2002-06-28 |
2010-11-15 |
Protiva Biotherapeutics Inc |
Verfahren und vorrichtung zur herstellung von liposomen
|
US7682626B2
(en)
|
2003-02-07 |
2010-03-23 |
Roche Madison Inc. |
Polyvinylethers for delivery of polynucleotides to mammalian cells
|
EP2567693B1
(en)
|
2003-07-16 |
2015-10-21 |
Protiva Biotherapeutics Inc. |
Lipid encapsulated interfering RNA
|
NZ592917A
(en)
|
2003-09-15 |
2012-12-21 |
Protiva Biotherapeutics Inc |
Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
|
US7745651B2
(en)
|
2004-06-07 |
2010-06-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use
|
US7799565B2
(en)
|
2004-06-07 |
2010-09-21 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering RNA
|
US7883688B2
(en)
|
2005-02-03 |
2011-02-08 |
Agency For Science, Technology And Research |
Polycationic polyrotaxanes capable of forming complexes with nucleic acids
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
CA2597724A1
(en)
|
2005-02-14 |
2007-08-02 |
Sirna Therapeutics, Inc. |
Cationic lipids and formulated molecular compositions containing them
|
AU2006274413B2
(en)
|
2005-07-27 |
2013-01-10 |
Arbutus Biopharma Corporation |
Systems and methods for manufacturing liposomes
|
MX2009003548A
(es)
|
2006-10-03 |
2009-04-15 |
Alnylam Pharmaceuticals Inc |
Formulaciones que contienen lipidos.
|
MX2009012568A
(es)
|
2007-05-22 |
2009-12-08 |
Mdrna Inc |
Oligonucleotidos de acido ribonucleico sustituidos con hidroximetilo y complejos de acido ribonucleico.
|
WO2009086558A1
(en)
|
2008-01-02 |
2009-07-09 |
Tekmira Pharmaceuticals Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
WO2009127060A1
(en)
*
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
CN101603042B
(zh)
*
|
2008-06-13 |
2013-05-01 |
厦门大学 |
可用于乙型肝炎病毒感染治疗的rna干扰靶点
|
JP5642673B2
(ja)
|
2008-07-10 |
2014-12-17 |
セリナ・セラピユーテイツクス・インコーポレーテツド |
不活性末端基を有するポリオキサゾリン類、保護された開始基から調製されるポリオキサゾリン類及び関連化合物
|
US20110071208A1
(en)
|
2009-06-05 |
2011-03-24 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated dicer-substrate interfering rna
|
CA2767127A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
US8569256B2
(en)
*
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
CN113430196A
(zh)
*
|
2011-06-30 |
2021-09-24 |
箭头药业股份有限公司 |
用于抑制乙型肝炎病毒的基因表达的组合物和方法
|
SG11201501255PA
(en)
*
|
2012-08-30 |
2015-03-30 |
Replicor Inc |
Methods for the treatment of hepatitis b and hepatitis d infections
|
KR20170075742A
(ko)
*
|
2014-10-02 |
2017-07-03 |
프로티바 바이오쎄라퓨틱스, 인코포레이티드 |
B형 간염 바이러스 유전자 발현을 제거하는 조성물 및 방법
|